GAMP® 5 as applied to FDA software validation - strategies to avoid warning letters | Wednesday, January 21st, 2015 | Palo Alto, United States

Contact Person : Referral; Last Date for the submission of abstract : Not Available ; Description : This training on combination product regulations will evaluate the chief areas of concern or change in the new CGMP requirements for combination products, 21 CFR Part 4,

Comments

Order by:

expand all

Per page:

There are no comments yet

Location

Location is undefined

Edit Location

Venues

Empty

Rate

0 votes

Recommend

Home

›

Events

›

GAMP® 5 as applied to FDA software validation - strategies to avoid warning letters

About Us Privacy Terms FAQ Contact Us